Biden begins radiation for prostate cancer
Digest more
Only men with prostate tumors of the luminal B subtype benefited from adding apalutamide to salvage radiation in the phase 2 ...
A genetic test could guide the use of hormone therapy for men with recurrent prostate cancer after surgery, according to data presented at American Society for Radiation Oncology Annual Meeting.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback